Cargando…
c-MET通路和抑制剂在非小细胞肺癌中的研究进展
c-MET is considered a promising oncogenic driver in non-small cell lung cancer (NSCLC) after the discovery of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). MET activation including gene mutation, amplification and protein overexpression, all of these are potential the...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999681/ https://www.ncbi.nlm.nih.gov/pubmed/28442019 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.10 |